Dhoot Transmission, Molbio Diagnostics IPOs list strong with 21-38% gains
The IPOs of both companies received a robust market response
Shares of Dhoot Transmission and Molbio Diagnostics made strong initial market debuts on Monday, with both companies posting gains of 21-38% over their IPO prices. Dhoot Transmission listed at a 38% premium on the NSE, while Molbio Diagnostics debuted at a 21.4% premium. Both companies experienced strong subscriptions, with Dhoot Transmission's IPO being subscribed 74.21 times overall and Molbio Diagnostics' IPO being subscribed 70.26 times overall.
The companies raised ₹918.3 crore and ₹281.5 crore, respectively, from anchor investors. Experts noted that both companies have strong positions in their respective markets, with Dhoot Transmission leading in wiring harnesses and Molbio Diagnostics leading in molecular diagnostics. Investors were advised to hold the stocks with stop-losses around the listing prices, while some recommended booking partial profits at the listing premium.
Written by urgent.news from Hindu BusinessLine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
